Evaluation of the XIENCE™ V Everolimus-Eluting Coronary Stent System in the Female Latin American Population of the SPIRIT Women Single-Arm Study: One-year Clinical Follow-up Data
| Autor: | Pedro A. Lemos, Cecile Dorange, José M. Torres Viera, Marie Claude Morice, Carla Agatiello, Jorge A. Belardi, Liliana Grinfeld, Marcos Antonio Marino, Alexandre Abizaid, Marrianne Stuteville, Florencia Rolandi |
|---|---|
| Jazyk: | angličtina |
| Předmět: |
Target lesion
medicine.medical_specialty Latin Americans medicine.medical_treatment Population Doença da artéria coronariana Coronary artery disease Stents farmacológicos Lesion América Latina Coronary stent medicine Women education Drug-eluting stents education.field_of_study Everolimus business.industry Stent General Medicine medicine.disease Surgery Mulheres Latin America medicine.symptom Cardiology and Cardiovascular Medicine business medicine.drug |
| Zdroj: | Revista Brasileira de Cardiologia Invasiva (English Edition). (3):239-246 |
| ISSN: | 2214-1235 |
| DOI: | 10.1016/S2214-1235(15)30060-0 |
| Popis: | BackgroundDrug-eluting stent trials have predominantly examined male populations of European descent. SPIRIT Women single-arm study evaluates the XIENCE™ V everolimus-eluting stent in complex de novo lesions in a real world female population, including Latin American patients. This analysis provides an insight into how this population responds to stenting when compared to non-Latin American patients.MethodsOf the 1,572 patients enrolled from 73 non-US sites, 138 (9%) were recruited from Argentina, Brazil and Venezuela.ResultsTarget lesions had reference vessel diameter ranging between 2.25mm and 4mm and lesion length |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|